Novo shares are a bargain, trading at 18 times earnings estimates. The catch is it's a wobbly time to invest – in May, the ...

Newsweek spoke to some experts about whether the weight loss drug could have an impact on birth rates in America.

Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.

GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists ...

The rise of GLP-1 drugs is a reminder that we must move beyond the simple equation of thinness as health and value. These ...

Driven by expensive drugs, hospital stays and growing behavioral health needs, healthcare spending is expected to keep rising ...

The United States officially won't be involved in an enhanced pandemic global response enacted by the World Health ...

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

Fintel reports that on July 18, 2025, Alliance Global Partners initiated coverage of Sound Point Meridian Capital, Inc. - ...

Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.